We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovative Device Closes Diseased Perforating Veins

By HospiMedica staff writers
Posted on 15 Nov 2007
An endovascular ablation device for the treatment of incompetent perforating veins (IPVs) is being used to treat specific varicose vein-related condition in the lower leg. More...


The VNUS ClosureRFS stylet is an endovenous radiofrequency (RF) ablation catheter that includes an integrated cable and a streamlined hub designed for easier use and better ergonomics. The device delivers RF energy via two bipolar electrodes at the distal tip of the rigid shaft to heat the perforator vein wall and create vein wall thickening and occlusion. A micro-thermocouple monitors temperature and provides continuous feedback to the physician. The ablation procedure can be performed either as a primary outpatient procedure or as an adjunct to saphenous vein ablation procedures. The ClosureRFS stylet is a product of VNUS Medical Technologies (San Jose, Ca, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"ClosureRFS is absolutely the best way of closing perforators, with none of the drawbacks of other techniques we have researched,” said Dr. Mark Whiteley, a vascular surgeon and director of The Whiteley Clinic (Surrey, England). "The beauty of the RFS Stylet is that the ultrasound lets you know exactly where you are at all times during the procedure, so it reduces or eliminates the risk of complications, and you're certain of getting successful ablation of the vein exactly at the point you want it.”

Perforating veins connect the superficial venous system to the deep veins. Valves within the calf and thigh perforators prevent blood from refluxing into the superficial venous system; if these valves become damaged and become incompetent, blood can then flow down the veins and puddle in the lower leg. Incompetent perforating veins have been linked to varicose veins and to chronic venous insufficiency in its most severe manifestation, venous ulceration.


Related Links:
VNUS Medical Technologies

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.